February 3, 2022 by Chain Drug Review
NCPA
Pharmacy
ALEXANDRIA, Va. – National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA, this week is reiterating his call to Federal Trade Commission Chair Lina Khan and Jonathan Kanter, Assistant Attorney General for the Department of Justice’s Antitrust Division, for the federal government to block UnitedHealth Group’s acquisition of data giant Change Healthcare. UHG owns
January 28, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce this upcoming event for pharmacists and pharmacy team members taking place in February: Feb. 10 – Immunization Information Systems: Key to Improving Vaccination Rates webinar. Documentation of vaccine administration has skyrocketed since vaccines became available for COVID-19. What does the future of immunization
January 20, 2022 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Pharmacists across the country are having a difficult time keeping up with the surging demand for at-home COVID-19 tests, according to a new survey by the National Community Pharmacists Association. “COVID-19 has caused shortages throughout the economy, but this is acute,” said NCPA CEO B. Douglas Hoey. “Community pharmacists are the first line of
January 18, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Community pharmacists on the front lines of the omicron surge are being forced to lose money to dispense new oral antiviral medicines based on the stingy fees paid by health insurance companies so far, said the National Community Pharmacists Association today in a letter to Centers for Medicare & Medicaid Services Administrator
January 14, 2022 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association and the American Pharmacists Association today issued the following statement in response to a decision by the U.S. District Court for the District of Columbia to grant a stay the case, NCPA v. Becerra, which challenges the legality of retroactive pharmacy price concessions, also known as pharmacy direct
January 6, 2022 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association issued the following statement today on behalf of CEO B. Douglas Hoey in response to a proposed Centers for Medicare & Medicaid Services rule posted this afternoon that would finally bring under control so-called pharmacy direct and indirect remuneration fees: “This is an encouraging development. We are grateful
December 21, 2021 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce these upcoming events for pharmacists and pharmacy team members taking place in January: Beginning Jan. 19 – Diabetes Accreditation Boot Camp. The NCPA Innovation Center is teaming up with PharmFurther to launch the Diabetes Accreditation Boot Camp, a new six-week online course that will
December 15, 2021 by Chain Drug Review
Diabetes Accreditation Boot Camp, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association’s Innovation Center is teaming up with PharmFurther to launch the Diabetes Accreditation Boot Camp, a new online course that will prepare pharmacy teams to provide Diabetes Self-Management Education and support for patients with diabetes. DSME is a billable, evidence-based service that allows pharmacy teams to improve patients’
December 14, 2021 by Chain Drug Review
Hoey, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Calls for federal investigations and actions to rein in pharmacy benefit managers are continuing to grow, with the influential Sen. Ron Wyden (D-Ore.) urging the Federal Trade Commission to investigate recent consolidations in the retail pharmacy market and assess whether large national pharmacy chains and health plans have acted to make this market less
December 8, 2021 by Chain Drug Review
DIR, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association is going live in the Washington, D.C. media market with a seven-figure television ad buy urging senators to finalize language to reform pharmacy direct and indirect remuneration (DIR) fees in Medicare Part D. DIR fee reform, which the Centers for Medicare & Medicaid Services said would save
December 2, 2021 by Chain Drug Review
Michele Belcher, NCPA, President Biden’s Executive Order on Promoting Competition in the American Economy
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – National Community Pharmacists Association president Michele Belcher, owner of Grants Pass Pharmacy in Grants Pass, Ore., today joined a virtual town hall hosted by the American Economic Liberties Project and featuring White House National Economic Council Director Brian Deese, National Economic Council Deputy Director Bharat Ramamurti, and Special Assistant to the President
December 1, 2021 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is proud to support the Drug Price Transparency in Medicaid Act of 2021, which would ban the use of spread pricing by pharmacy benefit managers in Medicaid managed care, require PBMs to reimburse pharmacies at a rate consistent with their acquisition plus a professional dispensing fee, and limit PBMs
November 29, 2021 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – Four pharmacy groups today filed a court brief in support of a Louisiana law requiring pharmacy benefit managers administering Medicare Part D plans to reimburse pharmacies a 10-cent provider fee. The case, Louisiana Independent Pharmacists Association v. Express Scripts, is the first test of a recent decision by the 8th Circuit Court of
November 18, 2021 by Chain Drug Review
NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The National Community Pharmacists Association is pleased to announce these upcoming NCPA Innovation Center Growth and Profitability events for pharmacists and pharmacy team members taking place in December: • Dec. 2 – NCPA Innovation Center’s Enhanced Services Boot Camp, in Little Rock, Ark., and with a virtual option. This is an intensive course